483
Bactolac Pharmaceutical, Inc.Bactolac Pharmaceutical, Inc. – FDA 483, Nov 19, 2021
Record Details
Bactolac Pharmaceutical, Inc. in Hauppauge, NY, was cited for significant deficiencies in its quality control and specification establishment for dietary supplements. Observations included failure to verify finished product specifications, not rejecting components exceeding heavy metal limits, and lacking established specifications for contamination and upper limits for ingredients. These issues indicate a lack of robust quality control processes for ensuring product safety and quality.
View Company Profile
ID · e212490d-5689-479c-bddb-1be40103b899
Other documents for Bactolac Pharmaceutical, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.